Walmart Settles Opioid Lawsuits for $3.1 Billion

Walmart becomes latest retail giant to cut deal, follows CVS Health and Walgreens
The Walmart logo is seen outside a Walmart store in Burbank, California on August 15, 2022. - Walmart, the largest retailer the United States, will report second quarter earnings on August 16, 2022. (Photo by Robyn Beck / AFP) (Photo by ROBYN BECK/AFP via Getty Images)

At a glance

  • On Tuesday, Walmart announced it had reached a settlement framework valued at $3.1 billion to resolve lawsuits with local, state, and tribal governments over its sale of opioids.
  • The settlement still needs to be approved by 43 states before becoming final.
  • The company said in a statement, “Walmart believes the settlement framework is in the best interest of all parties and will provide significant aid to communities across the country in the fight against the opioid crisis, with aid reaching state and local governments faster than any other nationwide opioid settlement to date, subject to satisfying all settlement requirements.”

Top News Stories

Sponsored